KUALA LUMPUR: Alpha IVF Group Bhd is accelerating its growth across Southeast Asia with strategic expansions into key markets such as Indonesia, China and the Philippines, looking to position itself as a regional leader in fertility care.
Alpha IVF Group is one of the largest fertility care specialists, currently operating in Malaysia and Singapore, with a focus on Assisted Reproductive Services (ARS), and a strong emphasis on In-vitro Fertilisation (IVF).
The group is extending its footprint into the three markets to tap into the demand market for fertility care with new centres and satellite clinics planned across the region.
"To support our ambitious growth targets, we are focused on developing new revenue streams through the planned establishment of additional IVF centres both in Malaysia and internationally," Alpha IVF Group Bhd group managing director Datuk Colin Lee Soon Soo said.
"Moreover, the group is preparing to open two more IVF centres in Malaysia by FY2026, bringing the total number of centres in the country to 5. "These expansion plans will not only make our success rates even more accessible to childless couples but also set the stage for us to become a leading IVF player in the region," he added.
Meanwhile, the group commited to distributing at least 60 per cent of its annual profit to shareholders, following an interim dividend payout post-initial public offering (IPO) of 0.45 sen per share on August 15 2024 in respect of the financial year ended May 31, 2024 (FY2024).
This translated to a RM21.9 million dividend payout post-listing.